OTCMKTS:FCPG First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free FCPG Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume15,858 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get First China Pharmaceutical Group alerts: Email Address Ad Huge AlertsTrending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! Click To Get Our Next Alert About First China Pharmaceutical Group Stock (OTCMKTS:FCPG)First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company’s short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers’ primary distributor, supplying more than 80% of the pharmaceutical products they require.Read More Ad Huge AlertsTrending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! Click To Get Our Next Alert FCPG Stock News HeadlinesMarch 28, 2024 | msn.comChina's Xiaomi to enter cut-throat EV market for the first timeMarch 1, 2024 | msn.comChina’s manufacturing activity contracts for 5th straight month despite policy supportMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 20, 2024 | morningstar.comChina Lesso Group Holdings Ltd 02128February 16, 2024 | msn.comPharmaceutical industry: public and private initiatives that are changing the gameJanuary 31, 2024 | msn.comCaixin survey shows China's factory activity expanded for a third month in January, extending divergence with official dataJanuary 4, 2024 | msn.comGlobal pharmaceutical firm Roche selects Malaysia as site for first-in-human clinical trial on experimental immunosuppressant drugDecember 29, 2023 | msn.comPharma firms urged to bring bird flu vaccines to PHMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. December 29, 2023 | msn.comCell and gene therapy will be top industry trend for pharma in 2024December 4, 2023 | benzinga.comPioneering health innovations at China Int'l Supply Chain ExpoNovember 29, 2023 | msn.comChina Pharma stock soars 115% on launch update for dry eye disease deviceNovember 26, 2023 | msn.comFocus: Indian drug manufacturers benefit from Big Pharma interest beyond ChinaNovember 24, 2023 | tmcnet.com515 companies, organizations to participate in first China International Supply Chain ExpoNovember 22, 2023 | morningstar.comChina Shineway Pharmaceutical Group LtdOctober 26, 2023 | wsj.comChina Shenghai Group Ltd.October 25, 2023 | msn.comFoxconn Subsidiary Investigation: A Microcosm of China-Taiwan TensionsOctober 25, 2023 | msn.com21 mind-blowing facts about the pharmaceutical industrySeptember 18, 2023 | seekingalpha.comCSPCY CSPC Pharmaceutical Group LimitedSeptember 1, 2023 | msn.comChina's Aug factory activity picks up unexpectedly - Caixin PMISeptember 1, 2023 | msn.comChina's factory activity unexpectedly expands to 51.0 in August amid efforts from BeijingAugust 29, 2023 | msn.comExpensive Drugs From Pfizer, Others Targeted for First U.S. Price NegotiationsAugust 29, 2023 | benzinga.comPharmaceutical Intermediates Market Predicted to Reach USD 53.4 billion by 2031, Expanding at a CAGR of 6% Says, Transparency Market ResearchAugust 26, 2023 | seekingalpha.comSFOSF Shanghai Fosun Pharmaceutical (Group) Co., Ltd.August 21, 2023 | msn.comChina's state investors to infuse $1.7B in wafer production plant in Shenzhen - reportAugust 9, 2023 | news.yahoo.comChina ranks 1st in world in scientific research output, most-cited papers: reportAugust 8, 2023 | msn.comMicrochip giant TSMC to open first ever European plantSee More Headlines Receive FCPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First China Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolOTCMKTS:FCPG CUSIP31948N109 CIK1432254 Webwww.firstchinapharma.com Phone+86-852-21381668FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key Competitors(BVII)OTCMKTS:BVII(CBNR)OTCMKTS:CBNR(DGTC)OTCMKTS:DGTC(DTOR)OTCMKTS:DTOR(EFLO)OTCMKTS:EFLOView All Competitors FCPG Stock Analysis - Frequently Asked Questions What other stocks do shareholders of First China Pharmaceutical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other First China Pharmaceutical Group investors own include Community Bank System (CBU), Owens & Minor (OMI) and ObsEva (OBSV). How do I buy shares of First China Pharmaceutical Group? Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:FCPG) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First China Pharmaceutical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.